LGV; Lymphogranuloma inguinale; Lymphopathia venereum
Lymphogranuloma venereum (LGV) is a sexually transmitted infection (STI).
LGV is a long-term (chronic) infection of the lymphatic system. It is caused by certain strains of the bacteria Chlamydia trachomatis. The bacteria are spread by sexual contact. The infection is not caused by the same strain of bacteria that causes genital chlamydia.
LGV is more common in Central and South America than in North America.
LGV is more common in men than women. The main risk factor is being HIV-positive.
Symptoms of LGV can begin a few days to a month after coming in contact with the bacteria. Symptoms include:
Your health care provider will examine you. You will be asked about your medical and sexual history. Tell your provider if you had sexual contact with someone you think has had symptoms of LGV.
A physical exam may show:
Tests may include:
LGV is treated with antibiotics, including doxycycline and erythromycin.
With treatment, the outlook is good and complete recovery can be expected.
Health problems that may result from LGV infection include:
Complications can occur many years after you are first infected.
Contact your provider if:
Not having any sexual activity is the only way to prevent an STI. Safer sex behaviors may reduce the risk.
The proper use of condoms, either the male or female type, greatly decreases the risk of catching an STI. You need to wear the condom from the beginning to the end of each sexual activity.
Batteiger BE, Tan M. Chlamydia trachomatis (trachoma, urogenital infections). In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 9th ed. Philadelphia, PA: Elsevier; 2020:chap 180.
Eckert LO, Lentz GM. Genital tract infections: vulva, vagina, cervix, toxic shock syndrome, endometritis, and salpingitis. In: Gershenson DM, Lentz GM, Valea FA, Lobo RA, eds. Comprehensive Gynecology. 8th ed. Philadelphia, PA: Elsevier; 2022:chap 23.
BACK TO TOPReview Date: 8/26/2023
Reviewed By: Jatin M. Vyas, MD, PhD, Associate Professor in Medicine, Harvard Medical School; Associate in Medicine, Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, MA. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
Health Content Provider
06/01/2025
|
A.D.A.M., Inc. is accredited by URAC, for Health Content Provider (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics. This site complied with the HONcode standard for trustworthy health information from 1995 to 2022, after which HON (Health On the Net, a not-for-profit organization that promoted transparent and reliable health information online) was discontinued. |
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2024 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.